Paradigm Biopharmaceuticals | PAR - Gross Profit On Sales

Stock Price
0.29
Daily Change
-0.02 -4.92%
Monthly
-14.71%
Yearly
-42.00%
Q1 Forecast
0.30

Paradigm Biopharmaceuticals reported AUD-9K in Gross Profit on Sales for its fiscal semester ending in June of 2025.





Gross Profit On Sales Change Date
Avita Medical AUD 14.95M 1.18M Jun/2025
Medical Developments International AUD 7.35M 7.37M Jun/2025
Neuren Pharmaceuticals AUD 6.69M 6.37M Jun/2025
Pacific Edge NZD 5.2M 1.75M Jun/2024
PYC Therapeutics AUD 5.83M 750K Jun/2025
Telix Pharmaceuticals AUD 129.12M 96.58M Dec/2024